Bank of New York Mellon »

Mirum Pharmaceuticals Inc Note 4.000 5/0 shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Mirum Pharmaceuticals Inc Note 4.000 5/0 shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Mirum Pharmaceuticals Inc Note 4.000 5/0

Tip: Access up to 7 years of quarterly data

All positions including Mirum Pharmaceuticals Inc Note 4.000 5/0 held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirum Pharmaceuticals Inc Note 4.000 5/0 by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2025-09-30 $237k 100k 2.37

More positions owned by Bank of New York Mellon

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Inc-class A Cl A (META)
Broadcom (AVGO)
Ishares Core S&p 500 Etf Core (IVV)
Alphabet Cl A (GOOGL)
Alphabet CL C (GOOG)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Berkshire Hathaway Inc-cl B CL B (BRK.B)
Exxon Mobil Corporation (XOM)
Mastercard Inc - A Cl A (MA)
Johnson & Johnson (JNJ)

View all positions for Bank of New York Mellon

Top funds holding Mirum Pharmaceuticals Inc Note 4.000 5/0

Deerfield Management Company
Readystate Asset Management
MacKay Shields
Tenor Capital Management
Citadel Advisors
Franklin Resources
Polar Securities
Capstone Investment Advisors
Bnp Paribas Arbitrage, Snc
Point72 Asset Management
FMR
Aristeia Capital
Aequim Alternative Investments
SSI Investment Management
Lord, Abbett & Co

View all funds holding Mirum Pharmaceuticals Inc Note 4.000 5/0